Dr. Grace Macaulay is a Safety Physician in Oncology within the patient safety department at MedImmune, part of Astra Zeneca Group. She is also studying part time for MSc in drug development at King’s College, London. Grace has two decades of specialist experience as a physician in oncology/haematology in Nigeria and the UK.
Prior to MedImmune, Grace lead the oncology team within Safety Surveillance and Risk Management at Mundipharma/NAPP Pharmaceutical Company in Cambridge Science Park. She started her industry career in 2006 after 10 years working and studying at King’s College Hospital, Denmark Hill, London. She was also sub-investigator for clinical trials in Oncology and Examiner in Breast cancer to Year 3 students at GKT (Guy’s, King’s, and St. Thomas’s) Hospitals. Grace has also played a key role as part of the team that set up ‘The London Clinic’ cancer centre on Devonshire/Harley Street, London.
She is a member of ASCO (American Society of Clinical Oncology) and ASH (American Society of Haematology).